12 insiders have filed at MRNA since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Bancel Stephane | Chief Executive Officer | 21.96M | 5.56% | 2 buys $5.0M | 1 sells $2.3M |
| Afeyan Noubar | Director | 6.86M | 1.736% | 193 sells $92.1M | |
| Hoge Stephen | President | 1.63M | 0.414% | 31 sells $31.1M | |
| Sagan Paul | Director | 494.1k | 0.125% | 1 buys $1.0M | |
| Klinger Shannon Thyme | Chief Legal Officer | 65.8k | 0.017% | 19 sells $2.3M | |
| Mock James M | Chief Financial Officer | 57.0k | 0.014% | 12 sells $1.0M | |
| Berenson Stephen | Director | 22.2k | <0.01% | ||
| Garay Arpa | Chief Commercial Officer | 3.7k | <0.01% | 2 sells $106k | |
| Nabel Elizabeth G | Director | 3.1k | <0.01% | ||
| Horning Sandra | Director | 2.4k | <0.01% | ||
| Rubenstein David M. | Director | 1.5k | <0.01% | ||
| Hussain Abbas | Director | 1.5k | <0.01% | 2 sells $23k |
Full register at boothcheck.com/insiders/MRNA. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.